Press "Enter" to skip to content

New patent for Intra-cellular drug CAPLYTA

0
Copyright © DrugPatentWatch. Originally published at New patent for Intra-cellular drug CAPLYTA

Annual Drug Patent Expirations for CAPLYTA
Annual Drug Patent Expirations for CAPLYTA

Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug.

CAPLYTA drug price trends.

Drug patent litigation for CAPLYTA.

This drug has one hundred and five patent family members in nineteen countries.

The generic ingredient in CAPLYTA is lumateperone tosylate. Additional details are available on the lumateperone tosylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Intra-cellular drug CAPLYTA
    DrugPatentWatch - Make Better Decisions